Arvee Laboratories (India) Ltd

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 17 Mar 2026, closing at ₹147.07, down 5.0% from the previous close. The stock faced intense selling pressure, with panic selling and unfilled supply driving the maximum permissible daily loss, signalling a sharp negative sentiment among investors in the Chemicals & Petrochemicals sector.

Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, surged to hit its upper circuit limit on 16 Mar 2026, registering a maximum daily gain of 5.0%. This sharp price movement reflects intense buying interest despite the company’s recent downgrade to a Strong Sell rating, underscoring a complex market dynamic around the stock.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 13 March 2026, providing investors with the latest perspective on the company’s position.

Arvee Laboratories (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook.

Arvee Laboratories (India) Ltd witnessed a robust surge in its share price on 5 Mar 2026, hitting the upper circuit limit of 5.0% to close at ₹158.97. This sharp rally was driven by intense buying interest, resulting in a maximum permissible daily gain and a regulatory trading freeze to curb excessive volatility.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 March 2026, providing investors with the latest perspective on the company’s position.

Shares of Arvee Laboratories (India) Ltd witnessed a sharp decline on 23 Feb 2026, hitting the lower circuit limit of ₹159.01, marking a maximum daily loss of 4.99%. The stock underperformed its Chemicals & Petrochemicals sector peers and the broader market, reflecting intense selling pressure and panic among investors.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 20 Feb 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹161.27, down 5.0% on the day, marking its maximum permissible daily loss and signalling heightened market anxiety around this Chemicals & Petrochemicals micro-cap.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 19 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Arvee Laboratories (India) Ltd has seen a marked shift in its valuation parameters, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios escalating to levels that now classify the stock as very expensive. This change accompanies a downgrade in its Mojo Grade to Strong Sell, reflecting growing concerns over its price attractiveness relative to historical and peer benchmarks within the Chemicals & Petrochemicals sector.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 9 Feb 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹155.09, down 4.82% on the day, marking its maximum permissible daily loss and underperforming both its sector and the broader market indices.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 08 February 2026, providing investors with the latest perspective on the company’s position.

Shares of Arvee Laboratories (India) Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by robust buying interest and a maximum daily gain of 3.48%. The stock closed at ₹161.01, marking a ₹5.42 rise from the previous close, reflecting heightened investor enthusiasm despite the company’s current strong sell rating.

Arvee Laboratories (India) Ltd witnessed a robust surge in its share price on 1 Feb 2026, hitting the upper circuit limit of 5%, closing at ₹164.72. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain and a regulatory trading freeze to contain volatility. Despite its micro-cap status and a recent downgrade to a Strong Sell rating, the stock outperformed its sector and the broader Sensex, signalling notable market attention.

Arvee Laboratories (India) Ltd witnessed robust buying interest on 28 Jan 2026, hitting its upper circuit limit with a maximum daily gain of 4.98%. The stock closed at ₹156.53, marking a significant outperformance against its sector and the broader market, driven by unrelenting demand and a regulatory freeze on further price movement.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 21 Jan 2026, reflecting intense selling pressure and panic among investors. The stock declined by 5.0%, closing at ₹152.64, marking its maximum permissible daily loss and signalling a sharp negative sentiment in the Chemicals & Petrochemicals sector.